ANAVEX LIFE SCIENCES CORP. (AVXL) Operating cash flow 2016–2025
ANAVEX LIFE SCIENCES CORP. (AVXL) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$39.0MFY2025 · since FY2016: -$9.2M → -$39.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$39.0M | -26.7% |
| FY2024 | -$30.8M | -10.9% |
| FY2023 | -$27.8M | -14.6% |
| FY2022 | -$24.2M | +20.2% |
| FY2021 | -$30.4M | -42.7% |
| FY2020 | -$21.3M | -14.9% |
| FY2019 | -$18.5M | -47.2% |
| FY2018 | -$12.6M | -39.5% |
| FY2017 | -$9.0M | +2.4% |
| FY2016 | -$9.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AVXL financial trends
AVXL RevenueAVXL Net incomeAVXL Net marginAVXL Gross profitAVXL Gross marginAVXL Operating incomeAVXL Operating marginAVXL Free cash flowAVXL Capital expendituresAVXL Return on equityAVXL Stock buybacksAVXL Dividends paidAVXL Total assetsAVXL Total liabilitiesAVXL Shareholders’ equityAVXL overview →